Department of Health Policy Archive — Page 5 of 15

June 21, 2022

Aliyu named director of Vanderbilt Institute for Global Health

Renowned physician-epidemiologist Muktar Aliyu, MBBS, MPH, DrPH, who is the associate director for Research with the Vanderbilt Institute for Global Health (VIGH), has been named the new director of the institute, beginning July 1.

June 9, 2022

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.

June 8, 2022

Capacity-building grant trains biostatisticians in West Africa

The Vanderbilt Institute for Global Health, Vanderbilt Department of Biostatistics, and Aminu Kano Teaching Hospital (AKTH) have partnered on a new program to train a cohort of highly skilled Nigerian biostatisticians to lead and supervise high-level biostatistics activities for HIV research studies in West Africa. 

May 10, 2022

New study illustrates how much it would cost for cancer drugs covered under Medicare Part D

A new study by Vanderbilt researchers highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit.

April 13, 2022

Study compares moral injury in health care workers and veterans

A study comparing 618 military veterans who deployed to a combat zone after Sept. 11, 2001, and 2,099 health care workers (HCWs) working during the COVID-19 pandemic found similar levels of potential moral injury (PMI), with 46.1% of veterans and 50.7% of HCWs reporting PMI.

April 4, 2022

Medicare beneficiaries without low-income subsidies were less likely to fill important prescriptions, new study finds

Vanderbilt research shows that Medicare Part D beneficiaries who did not receive federal subsidies to lower their out-of-pocket costs were nearly twice as likely as others to not fill prescriptions for serious health conditions like cancer or hepatitis C treatment.